key: cord-1053810-4nltkrje authors: Calvillo, Katherina Zabicki; Blair, Sarah L.; Kuerer, Henry M. title: 22nd Annual Virtual Meeting of the American Society of Breast Surgeons: Science, Innovation, and Practice Changes date: 2021-08-07 journal: Ann Surg Oncol DOI: 10.1245/s10434-021-10523-y sha: 17b6fd23cd761c1e5a2660550ae5022312e067ed doc_id: 1053810 cord_uid: 4nltkrje nan Unprecedented times call for unprecedented measures, which can yield unprecedented outcomes. Just weeks prior to what was planned to be an in-person meeting, the COVID-19 pandemic did not allow the 22nd Annual Meeting of the American Society of Breast Surgeons (ASBrS) to take place safely in person in Las Vegas, Nevada for a second year in a row. The Board of the ASBrS made the prudent decision to change the meeting from an in-person to a virtual platform, prioritizing the safety of its members, staff, and faculty, while fulfilling the society's mission to educate its membership and keep it connected, something greatly needed in socially distant times. The desire to connect and acquire new knowledge was evidenced by this year's highest record of meeting attendees in its 22-year history, with 1715 registrants present from 39 countries. This year's meeting offered a whole new event experience, while bringing the same energy, spirit, and collaboration consistent with all the Society's annual meetings. In addition, the virtual meeting platform continues to allow individuals to register and have access to all of the recorded presentations and to the 2021 Extended Annual Meeting Series being given through December 2021. The theme of this year's meeting was delivering valuebased care with a patient-centered approach, covering topics such as timing of neoadjuvant therapy, axillary surgery decisions, deescalation of therapy, and multimodality treatment of inflammatory breast cancer. The Great Debates included clipping axillary lymph nodes, postmastectomy radiation therapy in T1/2N1 disease, and routine sentinel node biopsy in post-menopausal ER?/ HER2-disease. 1,2 Dr. Jill Dietz delivered an excellent Presidential Address on the impact of COVID-19 on patients, medical providers, and healthcare, the Society's role in guiding breast cancer care around the world through collaboration, and the lessons we have learned that will affect the value, care and patient outcomes in the future. 3 The ASBrS Lifetime Achievement Award, deferred from last year, was presented to Dr. David P. Winchester by his son, Dr. David J. Winchester. With an emphasis on patient-centered care, the highlight of the meeting was the Keynote Address, ''It's the Little Things That Matter,'' masterfully delivered by UK breast surgeon, author, and TED talk speaker Liz O'Riordan, FRCS, PhD, PG Dip. 4 Dr. O'Riordan was diagnosed with stage III breast cancer in 2015 at the age of 40 years, started an award-winning blog about her experiences as a doctor and a patient, which led to her lecturing internationally about how to improve the quality of patient care, before being diagnosed with a chest wall recurrence in 2018. Her compelling keynote speech (available for view on the ASBrS website to members and nonmembers) highlights the three critical things that all healthcare This year's focus was on the latest science, innovations, and practice-changing information for breast surgeons. There were creative learning opportunities, lively debates, two new very well-attended virtual trainee poster discussion sessions, and the latest updates in our field. This historic past year and a half renewed our commitment to helping attendees elevate standard practice by improving the efficacy, safety, and quality of breast care for our patients and sharing the best of these advancements in this year's breast issue of the Annals of Surgical Oncology. This year, the George Peter's Award for the best presentation by a fellow went to Dr. Leisha Elmore from MD Anderson Cancer Center for her work on the contemporary incidence and survival clinical impact of local regional progression during neoadjuvant systemic therapy. 5 The annual Outstanding Scientific Presentation Award for the best abstract presented by a resident, medical trainee, or fellow went to Dr. Ayat ElSherif from the Cleveland Clinic for her work on antibiotic prophylaxis for nipple-sparing mastectomy with immediate breast reconstruction. 6 The Scientific Impact Award went to Dr. David Lim from the Toronto Women's College Research Institute on the relationship between the breast tumor pathologic response to neoadjuvant systemic therapy and axillary nodal response. 7 Much gratitude is given to the 31 members of the Publication Committee for careful blinded review (to both authors and institutional source) of 220 research abstracts for selection of the top studies for oral scientific, ''quickshot,'' and poster-discussion presentations, and for the final review and selection of the highest impact publications for this issue of Annals of Surgical Oncology.Just some of the highlighted research studies published in this issue of Annals of Surgical Oncology include important work regarding post-operative pain management, 8 understanding current axillary management, 9,10 potential new methods for decreasing surgery for margin control, 11 inflammatory breast cancer, 12 cryoablation without surgery for early invasive breast cancer, 13 and how the COVID-19 pandemic has altered practice among our society members. 14 These and other ASBrS articles published in this issue provide current research results germane to today's delivery of high-quality breast cancer care. DISCLOSURE The authors declare no conflict of interest. Debate: postmastectomy radiation therapy in T1/ 2N1 disease Current surgical management of inflammatory breast cancer Presidential address: 2020 is hindsight Keynote address: it's the little things that matter Clinical course of breast cancer patients with local regional progression during neoadjuvant systemic therapy Nipple sparing mastectomy: Are we providing proper prophylactic antibiotic coverage? The relationship between breast and axillary pathologic complete response in women receiving neoadjuvant chemotherapy for breast cancer Postdischarge nonsteroidal anti-inflammatory drugs are not associated with risk of hematoma after lumpectomy and sentinel lymph node biopsy with multimodal analgesia A national survey of breast surgeons and radiation oncologists on contemporary axillary management in mastectomy patients Controversial areas in axillary staging: Are we following the guidelines? High resolution full 3D specimen imaging for lumpectomy margin assessment in breast cancer Inflammatory breast cancer at the extremes of age Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial Analysis of the impact of the COVID-19 pandemic on the multidisciplinary management of breast cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery registries Is the 21-gene recurrence score on core needle biopsy equivalent to surgical specimen K Objective assessment of post-operative morbidity following breast cancer treatments with wearable activity monitors-the ''BRACELET'' study Contralateral axillary nodal metastases: Stage IV disease or a manifestation of progressive locally advanced breast cancer? Apocrine breast cancer: Unique features of a predominantly triple negative breast cancer Cutting instruments to cut costs: a simple initiative with breast surgical OR trays that resulted in substantial savings Improvement in breast reconstruction disparities following medicaid expansion under the affordable care act The impact of temporal variation in indocyanine green administration on tumor identification during fluorescence guided breast surgery Institutions treating breast cancer patients of a low socioeconomic status achieve multidisciplinary quality standards at lower rates Implementation of intraoperative ultrasound localization for breast conserving surgery in a large, integrated health care system is feasible and effective How protective are nipple-sparing prophylactic mastectomies in BRCA1 and BRCA2 mutation carriers? Assessing interobserver variability of cosmetic outcome assessment in breast cancer patients undergoing breast conservation surgery The new normal? Patient satisfaction and usability of telemedicine in breast cancer care Early trajectories of patient reported outcomes in breast cancer patients undergoing lumpectomy versus mastectomy Decision regret about breast cancer surgery-the WhySurg study Improving the breast surgeon's ergonomic workload for nipple-sparing mastectomies using exercise and an operating room positioning protocol Two-stage versus one-stage nipple sparing mastectomy: timing of surgery prevents nipple loss Impact of Choosing Wisely recommendations on sentinel lymph node biopsy and postoperative radiation rates in women over age 70 with hormone positive breast cancer Invasive lobular breast cancer: data to support surgical decision making Neoadjuvant endocrine therapy as an alternative to neoadjuvant chemotherapy among hormone receptor positive breast cancer patients: pathologic and surgical outcomes American society of breast surgeons practice patterns for patients at-risk and affected by breast cancer-related lymphedema Full abstract to published manuscript: evaluation of the scientific impact of American society of breast surgeons conference Mortality in older patients with breast cancer undergoing breast surgery: How low is ''low risk Multidisciplinary review of intraductal papilloma of the breast can identify patients who may omit surgical excision A 5-year breast surgeon experience in LYMPHA at the time of ALND for the treatment of clinical T1-4N1-3M0 breast cancer Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations